These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 1881712

  • 1. [The pancreas as a source of natural diabetogenic factor in alloxan diabetes].
    Kudriashov BA, Tarasov IuA, Ul'ianov AM.
    Patol Fiziol Eksp Ter; 1991; (2):46-7. PubMed ID: 1881712
    [Abstract] [Full Text] [Related]

  • 2. [Functional changes in the state of the insular system of animals after intravenous administration of diabetogenic factor].
    Kudriashov BA, Ul'ianov AM, Liapina LA.
    Vopr Med Khim; 1986; 32(5):57-9. PubMed ID: 3535246
    [Abstract] [Full Text] [Related]

  • 3. [Diabetogenic action of alloxan in short-term termination of the blood supply to the pancreas and spleen].
    Ul'ianov AM, Tarasov IuA.
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1984; (8):48-51. PubMed ID: 6487685
    [Abstract] [Full Text] [Related]

  • 4. [Stable reduction of endogenous insulin production in the body in experimental insulin-dependent diabetes].
    Kudriashov BA, Ul'ianov AM.
    Vopr Med Khim; 1991; 37(4):40-3. PubMed ID: 1750208
    [Abstract] [Full Text] [Related]

  • 5. [Role of the pancreas in the appearance of the diabetogenic factor during the development of alloxan diabetes].
    Kudriashov BA, Tarasov IuA, Ul'ianov AM.
    Patol Fiziol Eksp Ter; 1989; (3):75-9. PubMed ID: 2797907
    [Abstract] [Full Text] [Related]

  • 6. [Role of the diabetogenic factor in hypercoagulation of the blood].
    Kudriashov BA, Liapina LA, Ul'ianov AM.
    Fiziol Zh SSSR Im I M Sechenova; 1986 Mar; 72(3):373-6. PubMed ID: 3709867
    [Abstract] [Full Text] [Related]

  • 7. [Role of the diabetogenic factor in the activation of the blood coagulation system in experimental alloxan diabetes].
    Kudriashov BA, Ul'ianov AM, Liapina LA.
    Patol Fiziol Eksp Ter; 1986 Mar; (4):44-7. PubMed ID: 3797076
    [No Abstract] [Full Text] [Related]

  • 8. [The role of endogenous heparin in the protection against risk factors causing experimental diabetes].
    Kudriashov BA, Ul'ianov AM, Tarasov IuA.
    Vopr Med Khim; 1989 Mar; 35(6):80-2. PubMed ID: 2629244
    [Abstract] [Full Text] [Related]

  • 9. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats.
    Liu Z, Li J, Zeng Z, Liu M, Wang M.
    Chem Biol Interact; 2008 May 09; 173(1):68-75. PubMed ID: 18377884
    [Abstract] [Full Text] [Related]

  • 10. [Prophylactic effect of vitamin A, neutralizing the development of experimental insulin-dependent diabetes in animals].
    Kudriashov BA, Ul'ianov AM, Tarasov IuA.
    Vopr Med Khim; 1993 May 09; 39(1):20-2. PubMed ID: 8498064
    [Abstract] [Full Text] [Related]

  • 11. [Characteristics of the protein isolated from a blood albumin fraction in normal states and in diabetes].
    Liapina LA, Kudriashov BA, Baratova LA.
    Vopr Med Khim; 1987 May 09; 33(6):69-71. PubMed ID: 3445550
    [Abstract] [Full Text] [Related]

  • 12. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan.
    Yale JF, Grose M, Videtic GM, Marliss EB.
    Diabetes Res; 1986 Mar 09; 3(3):161-7. PubMed ID: 2940045
    [Abstract] [Full Text] [Related]

  • 13. [Complex-formation of heparin with the plasma diabetogenic factor].
    Kudriashov BA, Liapina LA.
    Vopr Med Khim; 1986 Mar 09; 32(2):64-5. PubMed ID: 3705518
    [Abstract] [Full Text] [Related]

  • 14. The status of magnesium in rabbits with experimentally-induced diabetes mellitus.
    Bhimji S, Godin DV, McNeill JH.
    Horm Metab Res; 1986 Nov 09; 18(11):734-8. PubMed ID: 3539735
    [Abstract] [Full Text] [Related]

  • 15. Hepatic and pancreatic effects of polyenoylphosphatidylcholine in rats with alloxan-induced diabetes.
    Buko V, Lukivskaya O, Nikitin V, Tarasov Y, Zavodnik L, Borodinsky A, Gorenshtein B, Janz B, Gundermann KJ, Schumacher R.
    Cell Biochem Funct; 1996 Jun 09; 14(2):131-7. PubMed ID: 8640953
    [Abstract] [Full Text] [Related]

  • 16. Differential effect of saturated, monounsaturated, and polyunsaturated fatty acids on alloxan-induced diabetes mellitus.
    Suresh Y, Das UN.
    Prostaglandins Leukot Essent Fatty Acids; 2006 Mar 09; 74(3):199-213. PubMed ID: 16412622
    [Abstract] [Full Text] [Related]

  • 17. [Animal sensitivity to the diabetogenic action of alloxan during cold adaptation].
    Shorin IuP, Seliatitskaia VG, Nepomniashchikh GI, Pal'chikova NA, Khodova RR.
    Biull Eksp Biol Med; 1984 Aug 09; 98(8):240-2. PubMed ID: 6466864
    [Abstract] [Full Text] [Related]

  • 18. Pancreatic uptake of [2-(14)C]alloxan.
    Malaisse WJ, Doherty M, Ladrière L, Malaisse-Lagae F.
    Int J Mol Med; 2001 Mar 09; 7(3):311-5. PubMed ID: 11179513
    [Abstract] [Full Text] [Related]

  • 19. Pancreatic lipid peroxidation in alloxan-induced diabetes mellitus.
    Soto C, Muriel P, Reyes JL.
    Arch Med Res; 1994 Mar 09; 25(4):377-80. PubMed ID: 7858394
    [Abstract] [Full Text] [Related]

  • 20. [Influence of alloxan-diabetes in pregnant sows on body composition, glucose tolerance and insulin reaction of newborn piglets].
    Emmrich P, Gürtler H, Bierwolf B.
    Exp Clin Endocrinol; 1983 Aug 09; 82(2):208-15. PubMed ID: 6354730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.